Steve Ubl, the longtime CEO at medical device lobby AdvaMed, is reportedly leaving the organization after 17 years to take the top spot at the pharmaceutical industry’s largest trade group, the Pharmaceutical Research and Manufacturers of America or PhRMA. The Hill, citing an unnamed source, said that Ubl “will more than likely” take over as […]
Spinal Modulation
CEO says SNN ‘working hard’ on acquisitions trail | The week in medtech M&A
St. Jude Medical closes Spinal Modulation buy
Spinal Modulation closes enrollment in Axium chronic pain study
Spinal Modulation said it completed enrollment in a U.S. pivotal study of its Axium neurotransmitter system for the treatment of chronic pain.
St. Jude-backed Spinal Modulation enrolls 1st patient in pain management study
Pain management: St. Jude pays $40M for exclusive purchase option for Spinal Modulation
St. Jude Medical (NYSE:STJ) last week branded neurostimulation devices maker Spinal Modulation as its territory with a $40 million equity investment that gives St. Jude international distribution rights and an exclusive option to acquire the company down the road.
